Literature DB >> 34307330

Cell Phone Selfies: Clinching the Diagnosis of Iris Microhemangiomatosis.

Kenneth W Price1, John P Gorham2, Jill R Wells1.   

Abstract

Four patients presented with a history of "blood" or a "dark spot" in the eye captured on cell phone photos. These episodes prompted presentation to an ophthalmologist where they all had normal slit lamp exams without a hyphema at initial evaluation. With evidence of a spontaneous hyphema seen on photos, further testing was performed including iris fluorescein angiography which revealed hyperfluorescent iris margin vascular tufts, confirming the diagnosis of iris microhemangiomatosis in each patient. All cases were managed conservatively, and only 1 needed topical antihypertensives. Without these patient-initiated photos, the diagnosis of iris microhemangiomatosis would likely remain elusive as slit lamp exam was normal at the time of initial examination in all 4 cases. Ophthalmologists should be aware of this rare diagnosis in the event a patient comes with a cell phone selfie documenting a spontaneous hyphema, especially when emanating from pupillary border.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Hyphema; Microhemangiomatosis; Pathology of anterior segment; Selfie

Year:  2021        PMID: 34307330      PMCID: PMC8280434          DOI: 10.1159/000512343

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  14 in total

Review 1.  Ophthalmic imaging today: an ophthalmic photographer's viewpoint - a review.

Authors:  Timothy J Bennett; Chris J Barry
Journal:  Clin Exp Ophthalmol       Date:  2009-09-23       Impact factor: 4.207

2.  Clinical survey of 3680 iris tumors based on patient age at presentation.

Authors:  Carol L Shields; Swarupa Kancherla; Jinali Patel; Priya Vijayvargiya; Mayerling M Suriano; Emily Kolbus; Ami Badami; Priya Sharma; Emily Jacobs; Matt Voluck; Zina Zhang; Rishav Kansal; Patrick W Shields; Carlos G Bianciotto; Jerry A Shields
Journal:  Ophthalmology       Date:  2011-10-27       Impact factor: 12.079

Review 3.  Teleophthalmology For Anterior Segment Disease.

Authors:  Wen Fan Hu; Alice C Lorch
Journal:  Int Ophthalmol Clin       Date:  2019

4.  Vascular tumors of the iris in 45 patients: the 2009 Helen Keller Lecture.

Authors:  Jerry A Shields; Carlos Bianciotto; Brad E Kligman; Carol L Shields
Journal:  Arch Ophthalmol       Date:  2010-09

5.  Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients.

Authors:  Basil K Williams; Maura Di Nicola; Sandor Ferenczy; Jerry A Shields; Carol L Shields
Journal:  Am J Ophthalmol       Date:  2018-08-15       Impact factor: 5.258

6.  Diagnosis of Tensilon-Negative Ocular Myasthenia Gravis By Daily Selfie.

Authors:  Elan L Guterman; James V Botelho; Jonathan C Horton
Journal:  J Neuroophthalmol       Date:  2016-09       Impact factor: 3.042

Review 7.  The smartphone in medicine: a review of current and potential use among physicians and students.

Authors:  Errol Ozdalga; Ark Ozdalga; Neera Ahuja
Journal:  J Med Internet Res       Date:  2012-09-27       Impact factor: 5.428

8.  Smartphone applications for triaging adults with skin lesions that are suspicious for melanoma.

Authors:  Naomi Chuchu; Yemisi Takwoingi; Jacqueline Dinnes; Rubeta N Matin; Oliver Bassett; Jacqueline F Moreau; Susan E Bayliss; Clare Davenport; Kathie Godfrey; Susan O'Connell; Abhilash Jain; Fiona M Walter; Jonathan J Deeks; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2018-12-04

9.  Ophthoselfie: Detailed Self-imaging of Cornea and Anterior Segment by Smartphone.

Authors:  Abdullah Kaya
Journal:  Turk J Ophthalmol       Date:  2017-06-01

10.  Evaluation of the effectiveness of diagnostic & management decision by teleophthalmology using indigenous equipment in comparison with in-clinic assessment of patients.

Authors:  S C Gupta; Subodh Kumar Sinha; Abhishek B Dagar
Journal:  Indian J Med Res       Date:  2013-10       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.